Source: Virtual Congress 2021 – COVID-19 and management of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
R. Ratnakumar (London, United Kingdom), J. Fraser (London, United Kingdom), R. Nicholls (London, United Kingdom), J. Quint (London, United Kingdom), S. Bloch (London, United Kingdom). Lung nodule management in Covid-19;does postponed surveillance matter?. 3846

Member's Comments

No comment yet.

Related content which might interest you: Lung abscess – still a surgical management? Source: Eur Respir J 2006; 28: Suppl. 50, 271s Year: 2006 Lung abscess that needs intervention Source: International Congress 2017 – CC3 Difficult-to-treat respiratory infections Year: 2017 Management of incidental nodules in lung cancer screening: ready for prime-time? Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 Year: 2019 Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management? Source: Breathe 2008; 4: 233-239 Year: 2008 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Lung volume reduction surgery - an underutilised treatment? Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 The role of Surgical Lung Biopsy in Interstitial Lung Diseases. Is it mandatory in this time of multiple diagnostic procedures? Analysis of 186 patients surgically treated. Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Pneumothoraces in CT guided lung biopsies – Are we too cautious? Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 An assessment of nurse led follow up of pulmonary nodules Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Some aspects of antioxidant protection in patients with tuberculosis after lung parenchyma sparing resection Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Changes in pulmonary function in patients with lung tuberculoma Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Bronchoscopic Lung Volume Reduction. Where do we stand? Source: School Course 2013 - Hands-on Course on Interventional Bronchoscopy Year: 2013 Is there still a diagnostic indication for surgical lung biopsy in Interstitial Lung Diseases? A Comparative study between Cryobiopsy and Surgical Biopsy on 677 patients. Source: International Congress 2018 – General thoracic surgery Year: 2018 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007 Complications in the course of valval lung volume reduction in destructive lung tuberculosis treatment Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Clinical nurse specialist led image guided pleural interventions – Is it safe? Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment? Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016